Home
>
National Drug Code (NDC)
>
ORPHENADRINE CITRATE
ORPHENADRINE CITRATE - 42291-530-01 - (ORPHENADRINE CITRATE)
Drug Information of ORPHENADRINE CITRATE
| Product NDC: | 42291-530 |
| Proprietary Name: | ORPHENADRINE CITRATE |
| Non Proprietary Name: | ORPHENADRINE CITRATE |
| Active Ingredient(s): | 100 mg/1 & nbsp; ORPHENADRINE CITRATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ORPHENADRINE CITRATE
| Product NDC: | 42291-530 |
| Labeler Name: | AvKARE, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040368 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20000624 |
Package Information of ORPHENADRINE CITRATE
| Package NDC: | 42291-530-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (42291-530-01) |
NDC Information of ORPHENADRINE CITRATE
| NDC Code | 42291-530-01 |
| Proprietary Name | ORPHENADRINE CITRATE |
| Package Description | 100 TABLET in 1 BOTTLE (42291-530-01) |
| Product NDC | 42291-530 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ORPHENADRINE CITRATE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20000624 |
| Marketing Category Name | ANDA |
| Labeler Name | AvKARE, Inc. |
| Substance Name | ORPHENADRINE CITRATE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |
